Page last updated: 2024-09-04

gadolinium dtpa and Hyperlipoproteinemia Type II

gadolinium dtpa has been researched along with Hyperlipoproteinemia Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fitzpatrick, J; Hajnal, JV; Naoumova, RP; Neuwirth, C; O'Regan, DP; Potter, E; Schmitz, SA; Tosi, I1

Other Studies

1 other study(ies) available for gadolinium dtpa and Hyperlipoproteinemia Type II

ArticleYear
White matter brain lesions in midlife familial hypercholesterolemic patients at 3-Tesla magnetic resonance imaging.
    Acta radiologica (Stockholm, Sweden : 1987), 2008, Volume: 49, Issue:2

    Topics: Adult; Age Factors; Body Mass Index; Brain; Brain Diseases; Cholesterol; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Image Enhancement; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Observer Variation; Risk Assessment; Risk Factors

2008